electroCore (ECOR) EPS (Basic) Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | -25.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.53% |
| Dec 31, 2025 | 15.00% |
| Sep 30, 2025 | -29.03% |
| Jun 30, 2025 | -15.79% |
| Mar 31, 2025 | 11.32% |
| Dec 31, 2024 | 27.27% |
| Sep 30, 2024 | 54.41% |
| Jun 30, 2024 | 63.11% |
| Mar 31, 2024 | 57.26% |
| Dec 31, 2023 | 55.65% |
| Sep 30, 2023 | 43.33% |
| Jun 30, 2023 | 14.17% |
| Mar 31, 2023 | -3.33% |
| Dec 31, 2022 | 72.93% |
| Sep 30, 2022 | -2,100.00% |
| Jun 30, 2022 | -1,900.00% |
| Mar 31, 2022 | -990.91% |
| Dec 31, 2021 | -3,423.08% |
| Sep 30, 2021 | 160.00% |
| Jun 30, 2021 | 53.85% |
| Mar 31, 2021 | 59.26% |
| Dec 31, 2020 | 55.17% |
| Sep 30, 2020 | 72.22% |
| Jun 30, 2020 | 68.29% |
| Mar 31, 2020 | 42.55% |
| Dec 31, 2019 | 44.23% |
| Sep 30, 2019 | 45.45% |
| Jun 30, 2019 | -95.24% |
| Mar 31, 2019 | 61.48% |
| Dec 31, 2018 | 99.08% |